Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the first quarter ending March 31, 2014 on Thursday, May 8, 2014, after the U.S. financial markets close.
Management will provide an update on the company, discuss first quarter 2014 results, and discuss expectations for the future via conference call on Thursday, May 8, 2014 at 4:30 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
